Komori
Terumo (4543) · RiskMitigated

Changes in Accounting Standards and Tax Regulations

First written in FY2021. 2 of 6 entries say "Mitigated", first in FY2024-Q1. Latest entry: FY2025-H1.

6entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2021AdvancedFY2023 – FY2024-Q1RestatedFY2024-Q3 – FY20242021: 120212022: 020222023: 220232024: 32024
Same theme, other companies
Risk of Earnings Impact from Changes in Accounting Standards and TaxationA theme 49 companies write about · 48 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2024: 2 of 13 companies on the "Worse" side.

3 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 49 companies compared. The sentences above are computed from all 49.
Full recordFilings, disclosures and news, newest first
  1. FY2025-H1MitigatedAnnual report

    「The Group has applied the following standard from the current interim consolidated fiscal period. Standard: IAS 1. Title: Presentation of Financial Statements. Revision clarifying the requirements for classifying liabilities as current or non-current and requiring disclosure of information about non-current liabilities with covenants. The application of this standard had no material impact on the condensed interim consolidated financial statements.」

    Regarding the risk of changes in accounting standards, the Company applied the amendments to IAS 1 but explained that there was no material impact on the condensed interim consolidated financial statements.
  2. FY2024RestatedAnnual report

    「The Group has applied the following standard from the current consolidated fiscal year. There is no material impact on the consolidated financial statements for the current consolidated fiscal year. Standard: IAS 12. Income Taxes.」

    As a response to changes in accounting standards and tax legislation, the Group applied the amendments to IAS 12, but explained that there was no material impact on the consolidated financial statements for the current consolidated fiscal year.
  3. FY2024-Q3RestatedAnnual report

    「The Group has applied the following standard from the first quarter consolidated accounting period. Standard: IAS 12. Standard name: Income Taxes. Amendment clarifying the accounting treatment for deferred taxes on transactions involving leases and decommissioning obligations, among others, where an entity recognizes both an asset and a liability. The application of this standard has no material impact on the condensed quarterly consolidated financial statements for the period.」

    The Company continued to state that, although it applied the amendments to IAS 12, there was no material impact on the condensed quarterly consolidated financial statements for the period.
  4. FY2024-Q1MitigatedAnnual report

    「The Group has applied the following standard from the current first quarter of the consolidated fiscal year. Standard: IAS 12. Title: Income Taxes. Revision clarifying the accounting treatment of deferred tax for transactions involving leases and decommissioning obligations, etc. (transactions in which an entity recognizes both an asset and a liability). The application of this standard had no material impact on the condensed interim consolidated financial statements.」

    The Company explained that, although it applied the amendments to IAS 12, there was no material impact on the condensed quarterly consolidated financial statements for the period.
  5. FY2023AdvancedAnnual report

    「The Group has applied the following standards from the current consolidated fiscal year. There is no impact on the consolidated financial statements for the current consolidated fiscal year.」

    Regarding the risk of changes in accounting standards and tax legislation, the Group applied the amendments to IFRS 3 and IAS 12 from FY2023. It stated that there was no impact on the financial statements and that the impact of standards to be applied from the fiscal year ending March 2024 onward was under consideration.
  6. FY2021First statedAnnual report

    「However, if new accounting standards or tax legislation are introduced or changed at a time when it is difficult to obtain information in advance, or if additional tax liabilities arise due to differences in interpretation with tax authorities, this may affect the Company's business results and financial condition.」

    Disclosed the introduction or amendment of accounting standards and tax legislation, and additional burdens arising from differences in interpretation with tax authorities, as new standalone risks.
Moved together

"Growth in the Blood Systems business centered on apheresis, cell processing and emerging markets" moved the same way as this thread, in the same document, in 3 of its 6 moves.

333332★123456
  1. ★This thread
  2. 1Growth in the Blood Systems business centered on apheresis, cell processing and emerging markets3×
  3. 2Expanding market share in global markets and enhancing brand value3×
  4. 3Global sales expansion of cardiovascular products such as Ultimaster3×
  5. 4Strengthening Cost Competitiveness Through Products Tailored to Regional Needs and a Global Production Network3×
  6. 5Reinvestment of Retained Earnings in Research and Development, Production Facilities and Overseas Expansion3×
  7. 6Becoming a Company with a Strong Global Presence and Achieving Sustainable, Profitable, High-Quality Growth2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Terumo yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Changes in Accounting Standards and Tax Regulations | TERUMO CORPORATION (4543) | Komori